Translate

Search This Blog

Search Tool




May 22, 2018

From Burkina to Zimbabwe, U.S. aid cuts squeeze family planning services - May 22, 2018 -.| Reuters Health Report.


Reuters Health Report

 

From Burkina to Zimbabwe, U.S. aid cuts squeeze family planning services

OUAGADOUGOU (Reuters) - The Marie Stopes Ladies who drive from village to village in the remote north of Burkina Faso offering free contraception, advice on family planning, sexual health and sometimes abortion, may have to stop work in June.

Two new Ebola deaths recorded in Congo: health ministry

MBANDAKA, Democratic Republic of Congo (Reuters) - Two new deaths from Ebola and seven new confirmed cases have been recorded in Democratic Republic of Congo, the health ministry said on Tuesday.

Rare brain-damaging virus kills 10 in India, prompts rush to hospitals

BENGALURU/KOCHI (Reuters) - A rare virus spread by fruit bats, which can cause flu-like symptoms and brain damage, has killed 10 people in southern India, health officials said on Tuesday, with at least two more cases being monitored.

Congo begins giving experimental Ebola vaccine to medics

MBANDAKA, Democratic Republic of Congo (Reuters) - Congo began administering an experimental Ebola vaccine to medical staff in the northwestern city of Mbandaka on Monday to tackle an outbreak of the virus believed to have killed 26 people since early April.

Roche drug dramatically reduces bleeds in key hemophilia tests

LONDON (Reuters) - Roche's new hemophilia drug Hemlibra dramatically reduced bleeding in a broad population of hemophilia patients, results from two clinical trials showed on Monday, setting it up to take a dominant market position.

Dova Pharma's blood disorder drug gets FDA approval

(Reuters) - The U.S Food and Drug Administration said on Monday it had approved Dova Pharmaceuticals Inc's drug to treat low blood platelet count in chronic liver disease (CLD) patients, who are scheduled to undergo a medical procedure.

AstraZeneca potassium drug finally approved, threatening Vifor

LONDON (Reuters) - The decision by U.S. regulators to finally approve AstraZeneca's much-delayed excess potassium drug Lokelma gives the group another new medicine launch, boosting its portfolio as it strives to offset declining sales of older products.

China considers scrapping birth limits by 2019: Bloomberg

HONG KONG (Reuters) - China is considering ending the limits it sets on the number of children a family can have, Bloomberg reported on Monday, citing people familiar with the matter.

Strong grip may predict longer life at all ages

(Reuters Health) - Grip strength may be a better predictor of future health than some measurements doctors currently use to gauge risk, a large UK study suggests.

Egg a day tied to lower risk of heart disease

(Reuters Health) - People who eat an egg just about every day may have a lower risk of heart attack and stroke than individuals who don't eat eggs at all, a large Chinese study suggests.

Related Videos

Aquatic moss that removes arsenic from water discovered

Researchers at Stockholm University have discovered an aquatic moss capable of quickly removing arsenic from contaminated water. Miles Addy reports.

Hybrid-electric aircraft race heats up

Seattle's Zunum Aero is one of an estimated seventy companies worldwide, ranging from start-ups to the largest manufacturers, developing some form of hybrid-electric aircraft. Angela Moore reports